Skip to content

Longitudinal validation of the DHEQ-15 Brazilian questionnaire

Longitudinal validation of the Brazilian version of the Dentine Hypersensitivity Experience Questionnaire (DHEQ-15)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9fmjf77
Enrollment
Unknown
Registered
2024-03-31
Start date
2024-03-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin sensitivity

Interventions

This is a two-arm, triple-blind, randomized controlled clinical study. Experimental group: 50 participants with sensitive teeth will undergo dental hypersensitivity treatment with a glutaraldehyde-bas
D26.660

Sponsors

Universidade Federal dos Vales do Jequitinhonha e Mucuri
Lead Sponsor
Universidade Federal dos Vales do Jequitinhonha e Mucuri
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients complaining of dentin hypersensitivity with cold, sweets, acidic foods and brushing, and with clinical diagnosis of dentin hypersensitivity; both sexes; without distinction of color or socioeconomic condition; age over 18 years; with good general and oral health

Exclusion criteria

Exclusion criteria: Patients presenting restorations and carious lesions in the exposed dentin of hypersensitive teeth; who used painkillers, anti-inflammatories and antidepressants frequently; and presence of gingival inflammation

Design outcomes

Primary

MeasureTime frame
Improvement in oral health related quality of life, verified through the DHEQ-15 questionnaire (Dentin Hypersensitivity Experience, 15 items) from the finding of a decrease of at least 10 points in the total score of the questionnaire before and 90 days after intervention

Secondary

MeasureTime frame
Decrease in the level of dentin hypersensitivity, verified by means of thermal test with ice stick and evaporative test with air jet of the syringe triple, based on the decrease of at least 5% in the pre and post intervention hypersensitivity scores. Reassessments will be carried out immediately, 1 and 3 months after treatment

Countries

Brazil

Contacts

Public ContactDhelfeson Oliveira

Universidade Federal dos Vales do Jequitinhonha e Mucuri

dhelfeson@ufvjm.edu.br+55(38)35326013

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026